BGB-B455-101: A Phase 1, Open-Label Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B455 in Patients With Selected Advanced or Metastatic Solid Tumors

Objective

Clinical Trial Details

Principal Investigator(s)

David Starks, MD

Clinical Trial Categories

• Cancer
• Lung Cancer
• Gynecologic Cancer
• Esophageal/Gastroesophageal Junction (GEJ)

Contact

Gynecology Breast Coordinators at 605-322-7536
or gyn.breastresearch@avera.org